The stock of Oscar Health Inc (NYSE: OSCR) has decreased by -2.21 when compared to last closing price of 13.22. Despite this, the company has experienced a -16.76% fall in its stock price over the last five trading sessions. youtube.com reported 2025-03-13 that Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, discusses potential solutions to some of the problems in the health insurance industry and why he believes the individual insurance market is the solution for Americans.
Is It Worth Investing in Oscar Health Inc (NYSE: OSCR) Right Now?
The 36-month beta value for OSCR is also noteworthy at 1.75. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 1 rating it as “sell.”
The public float for OSCR is 175.86M, and at present, short sellers hold a 12.68% of that float. The average trading volume of OSCR on March 17, 2025 was 4.62M shares.
OSCR’s Market Performance
OSCR stock saw a decrease of -16.76% in the past week, with a monthly decline of -1.01% and a quarterly a decrease of -9.97%. The volatility ratio for the week is 8.12%, and the volatility levels for the last 30 days are 8.21% for Oscar Health Inc (OSCR). The simple moving average for the past 20 days is -13.93% for OSCR’s stock, with a -22.94% simple moving average for the past 200 days.
Analysts’ Opinion of OSCR
Many brokerage firms have already submitted their reports for OSCR stocks, with Wells Fargo repeating the rating for OSCR by listing it as a “Equal Weight.” The predicted price for OSCR in the upcoming period, according to Wells Fargo is $16 based on the research report published on March 13, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see OSCR reach a price target of $12. The rating they have provided for OSCR stocks is “Underperform” according to the report published on December 10th, 2024.
BofA Securities gave a rating of “Underperform” to OSCR, setting the target price at $13.50 in the report published on November 06th of the previous year.
OSCR Trading at -14.59% from the 50-Day Moving Average
After a stumble in the market that brought OSCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.66% of loss for the given period.
Volatility was left at 8.21%, however, over the last 30 days, the volatility rate increased by 8.12%, as shares sank -3.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.57% lower at present.
During the last 5 trading sessions, OSCR fell by -16.55%, which changed the moving average for the period of 200-days by -36.53% in comparison to the 20-day moving average, which settled at $15.02. In addition, Oscar Health Inc saw -3.81% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OSCR starting from ALESSANDREA QUANE, who proposed sale 700 shares at the price of $16.50 back on Mar 10 ’25. After this action, ALESSANDREA QUANE now owns shares of Oscar Health Inc, valued at $11,551 using the latest closing price.
ALESSANDREA QUANE, the Former Officer of Oscar Health Inc, proposed sale 5,101 shares at $16.50 during a trade that took place back on Mar 07 ’25, which means that ALESSANDREA QUANE is holding shares at $84,181 based on the most recent closing price.
Stock Fundamentals for OSCR
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 1.0 for the gross margin
The net margin for Oscar Health Inc stands at 0.0. The total capital return value is set at 0.04. Equity return is now at value 2.80, with 0.64 for asset returns.
Based on Oscar Health Inc (OSCR), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at 3.27. The debt to equity ratio resting at 0.3. The interest coverage ratio of the stock is 2.41.
Currently, EBITDA for the company is 88.62 million with net debt to EBITDA at -13.82. When we switch over and look at the enterprise to sales, we see a ratio of 0.17. The receivables turnover for the company is 29.05for trailing twelve months and the total asset turnover is 1.9. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
In summary, Oscar Health Inc (OSCR) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
